With the analysis among 110 patents, we discovered top 41 key players by total patent application. Hanmi Pharmaceutical Co., Ltd., Inflammatory Response Research, Inc., UCB Farchim SA are dominant in this area. They take 29.09% of the total patent filing.
Hanmi Pharmaceutical Co., Ltd.
Inflammatory Response Research, Inc.
California, United States
Patent: 10
Gelderland, Netherlands
Patent: 6
Hunan Jiudian Pharmaceutical Co., Ltd.
Hunan Sheng, China
Patent: 4
Glenmark Pharmaceuticals Ltd.
Maharashtra, India
Patent: 3
Pennsylvania, United States
Patent: 3
Maharashtra, India
Patent: 2
Taisho Pharmaceutical Co., Ltd.
No data, please try another search term
With the analysis among related 50 patents applied in the last 5 years. We discover 26 most active companies in this area. The fast-growing JDP Therapeutics LLC, Alkem Laboratories Ltd., Hanwha Pharma Co. Ltd. take 14.00% of patent filing during this period.
Pennsylvania, United States
Patent: 3
Maharashtra, India
Patent: 2
JIANGSU ALICORN PHARMACEUTICAL CO.,LTD
Jiangsu Sheng, China
Patent: 2
Taisho Pharmaceutical Co., Ltd.
Affiliated Hospital of Nantong University
Jiangsu Sheng, China
Patent: 2
Okinawa-ken, Japan
Patent: 2
Hunan Jiudian Pharmaceutical Co., Ltd.
Hunan Sheng, China
Patent: 2
Hubei Meilin Pharmaceutical Co. Ltd.
Hubei Sheng, China
Patent: 1
With the analysis among related 50 patents in last 5 years, we discover 23 new entrants. JDP Therapeutics LLC, Alkem Laboratories Ltd., Affiliated Hospital of Nantong University are the most active new entrants in this area.
Pennsylvania, United States
Patent: 3
Maharashtra, India
Patent: 2
Affiliated Hospital of Nantong University
Jiangsu Sheng, China
Patent: 2
Okinawa-ken, Japan
Patent: 2
JIANGSU ALICORN PHARMACEUTICAL CO.,LTD
Jiangsu Sheng, China
Patent: 2
Taisho Pharmaceutical Co., Ltd.
Xiamen Zixu Pharmaceutical Technology Co., Ltd.
Fujian Sheng, China
Patent: 1
Hubei Meilin Pharmaceutical Co. Ltd.
Hubei Sheng, China
Patent: 1
No data, please try another search term